S D Anker

Summary

Country: Germany

Publications

  1. doi request reprint A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)
    Stefan D Anker
    Innovative Clinical Trials, Department of Cardiology and Pneumonology, University Medical Centre Göttingen UMG, Robert Koch Str 40, Göttingen D 37075, Germany
    Eur Heart J 36:2297-309. 2015
  2. doi request reprint Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies
    Stefan D Anker
    Department of Innovative Clinical Trials, University Medical Centre Göttingen, Gottingen, Germany
    Eur Heart J 36:715-23. 2015
  3. doi request reprint The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
    Stefan D Anker
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin D 13353, Germany Department of Cardiology, University Medical Center, Gottingen, Germany
    Eur Heart J 35:2001-9. 2014
  4. pmc Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
    Stefan D Anker
    Department of Cardiology, Charite, Campus Virchow Klinikum, Augustenburger Platz 1, Berlin D 13353, Germany
    Eur J Heart Fail 11:1084-91. 2009
  5. pmc Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
    Markus S Anker
    Center for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy
    Arch Med Sci 9:166-71. 2013
  6. pmc Theophylline is able to partially revert cachexia in tumour-bearing rats
    Mireia Olivan
    Cancer Research Group, Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Diagonal 645, Barcelona, 08028, Spain
    Nutr Metab (Lond) 9:76. 2012
  7. doi request reprint Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure
    Anja Sandek
    Dept of Cardiology, Charite Universitatsmedizin, Berlin, Germany
    Int J Cardiol 157:80-5. 2012
  8. ncbi request reprint ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology
    S D Anker
    Division of Applied Cachexia Research, Department of Cardiology, Charite Universitatsmedizin Berlin, CVK, Berlin, Germany
    Clin Nutr 25:311-8. 2006
  9. doi request reprint Telemedicine and remote management of patients with heart failure
    Stefan D Anker
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
    Lancet 378:731-9. 2011
  10. ncbi request reprint Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
    K J Osterziel
    Franz Volhard Klinik am Max Delbrück Centrum für Molekulare Medizin, Charite, Humboldt Universitat zu Berlin, Germany
    Lancet 351:1233-7. 1998

Detail Information

Publications26

  1. doi request reprint A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)
    Stefan D Anker
    Innovative Clinical Trials, Department of Cardiology and Pneumonology, University Medical Centre Göttingen UMG, Robert Koch Str 40, Göttingen D 37075, Germany
    Eur Heart J 36:2297-309. 2015
    ..AUGMENT-HF was an international, multi-centre, prospective, randomized, controlled trial to evaluate the benefits and safety of a novel method of left ventricular (LV) modification with alginate-hydrogel...
  2. doi request reprint Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies
    Stefan D Anker
    Department of Innovative Clinical Trials, University Medical Centre Göttingen, Gottingen, Germany
    Eur Heart J 36:715-23. 2015
    ..This review summarizes preclinical and clinical data supporting the potential use of ularitide in the treatment of ADHF. ..
  3. doi request reprint The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
    Stefan D Anker
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin D 13353, Germany Department of Cardiology, University Medical Center, Gottingen, Germany
    Eur Heart J 35:2001-9. 2014
    ..This process of integrating PRO data into comprehensive efficacy evaluations will ultimately improve the quality of care for patients across the spectrum of cardiovascular disease. ..
  4. pmc Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia
    Stefan D Anker
    Department of Cardiology, Charite, Campus Virchow Klinikum, Augustenburger Platz 1, Berlin D 13353, Germany
    Eur J Heart Fail 11:1084-91. 2009
    ..gov NCT00520780) was designed to determine the effect of i.v. iron repletion therapy using ferric carboxymaltose on self-reported patient global assessment (PGA) and New York Heart Association (NYHA) in patients with CHF and ID...
  5. pmc Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
    Markus S Anker
    Center for Clinical and Basic Research, IRCCS San Raffaele, Rome, Italy
    Arch Med Sci 9:166-71. 2013
    ....
  6. pmc Theophylline is able to partially revert cachexia in tumour-bearing rats
    Mireia Olivan
    Cancer Research Group, Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Diagonal 645, Barcelona, 08028, Spain
    Nutr Metab (Lond) 9:76. 2012
    ..abstract:..
  7. doi request reprint Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure
    Anja Sandek
    Dept of Cardiology, Charite Universitatsmedizin, Berlin, Germany
    Int J Cardiol 157:80-5. 2012
    ..Small intestinal function may be altered in decompensated chronic heart failure (CHF) and translocating LPS may contribute to systemic inflammation observed in CHF...
  8. ncbi request reprint ESPEN Guidelines on Enteral Nutrition: Cardiology and pulmonology
    S D Anker
    Division of Applied Cachexia Research, Department of Cardiology, Charite Universitatsmedizin Berlin, CVK, Berlin, Germany
    Clin Nutr 25:311-8. 2006
    ..Frequent small amounts of ONS are preferred in order to avoid postprandial dyspnoea and satiety as well as to improve compliance...
  9. doi request reprint Telemedicine and remote management of patients with heart failure
    Stefan D Anker
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
    Lancet 378:731-9. 2011
    ..We are optimistic that telemedicine is an efficient approach and will become an important feature of management in heart failure...
  10. ncbi request reprint Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
    K J Osterziel
    Franz Volhard Klinik am Max Delbrück Centrum für Molekulare Medizin, Charite, Humboldt Universitat zu Berlin, Germany
    Lancet 351:1233-7. 1998
    ..We did a double-blind, randomised, placebo-controlled study of rhGH in patients with chronic heart failure due to dilated cardiomyopathy...
  11. doi request reprint ESPEN Guidelines on Parenteral Nutrition: on cardiology and pneumology
    S D Anker
    Department of Cardiology, Charite Universitatsmedizin, Berlin, Germany
    Clin Nutr 28:455-60. 2009
    ....
  12. doi request reprint Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol
    S von Haehling
    Applied Cachexia Research, Department of Cardiology, Charite Medical School, Campus Virchow Klinikum, Berlin, Germany
    Clin Pharmacol Ther 88:506-12. 2010
    ..02); postischemic vasodilation as well as endothelium-dependent vasodilation (both P < 0.05) improved. ADMA may be a pathophysiologic factor that is modulated by ROS accumulation and contributes to impaired vascular regulation in CHF...
  13. doi request reprint [Iron deficiency in chronic heart failure: from diagnosis to therapy]
    S von Haehling
    Zentrum für Angewandte Kachexieforschung, Medizinische Klinik mit Schwerpunkt Kardiologie, Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Berlin
    Dtsch Med Wochenschr 139:841-4. 2014
    ..Replenishing iron stores is most useful using the intravenous route, and administered doses need to be adjusted to individual needs...
  14. doi request reprint Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients
    S Baid-Agrawal
    Division of Nephrology and Medical Intensive Care, Department of Medicine, Berlin, Germany
    Am J Transplant 9:2777-84. 2009
    ....
  15. ncbi request reprint Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone
    S D Anker
    Franz Volhard Klinik, Max Delbrück Centrum for Molecular Medicine, Charite, Berlin, Germany
    J Am Coll Cardiol 38:443-52. 2001
    ..We aimed to determine whether growth hormone (GH) resistance is present in patients with chronic heart failure (CHF) and whether it may be linked to the biochemical response to GH treatment...
  16. doi request reprint Ferric carboxymaltose in patients with heart failure and iron deficiency
    Stefan D Anker
    Department of Cardiology, Campus Virchow Klinikum, Charite Universitatsmedizin, Berlin
    N Engl J Med 361:2436-48. 2009
    ....
  17. doi request reprint Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis
    T Szabo
    Applied Cachexia Research, Department of Cardiology, Charite Universitatsmedizin Berlin, Germany
    Nutr Metab Cardiovasc Dis 24:50-6. 2014
    ..We aimed to determinate an abnormal ADPN regulation as a link between catabolic signalling, symptomatic deterioration and poor prognosis...
  18. ncbi request reprint ["Partnership for the Heart"--development and testing of a new remote patient monitoring system]
    F Kohler
    Charite Universitatsmedizin, Berlin, Medizinische Klinik Schwerpunkt Kardiologie, Angiologie, Campus Charite Mitte, 10117 Berlin
    Dtsch Med Wochenschr 132:458-60. 2007
  19. ncbi request reprint Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation
    F M Brunkhorst
    Krankenhaus Zehlendorf, Department of Internal Medicine, Berlin, Germany
    Int J Cardiol 72:3-10. 1999
    ..It is known that blood procalcitonin rises in response to bacterial endotoxin exposure...
  20. ncbi request reprint Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure
    W Doehner
    Applied Cachexia Research, Dept of Cardiology, Charite Medical School, Campus Virchow Klinikum, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany
    Horm Metab Res 37:106-10. 2005
    ..Continuing experience in minimal model methodology has raised questions about how best to assign basal glucose concentrations during such analyses...
  21. pmc Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?
    S von Haehling
    Heart 91:1-2. 2005
    ..Statins are being hailed as the new aspirin--but are they beneficial for patients with heart failure?..
  22. ncbi request reprint Anemia in chronic heart failure--frequency and prognostic impact
    W Steinborn
    Imperial College, NHLI, Department of Clinical Cardiology, London, UK
    Clin Nephrol 60:S103-7. 2003
    ..However, the anemia seen in CHF is generally an "anemia of chronic illness". Furthermore, it has been shown that hemoglobin levels independently predict increased mortality in CHF...
  23. ncbi request reprint Anaemia is an independent predictor of poor outcome in patients with chronic heart failure
    J Szachniewicz
    Department of Cardiology, Military Hospital, ul Weigla 5, 50 891 Wroclaw, Poland
    Int J Cardiol 90:303-8. 2003
    ..The aim of this study was to assess prospectively the relationship between the prevalence of anaemia (haemoglobin level<or=120 g/l) and prognosis in an unselected CHF population...